Augmentin Dosing for 9-Year-Old with Mucoid AOM
For a 9-year-old child weighing 36 kg with mucoid acute otitis media, prescribe high-dose amoxicillin-clavulanate at 90 mg/kg/day of amoxicillin (3,240 mg/day total) with 6.4 mg/kg/day of clavulanate (230 mg/day total), divided into 2 doses (1,620 mg amoxicillin per dose), for 10 days.
Rationale for High-Dose Regimen
The 2013 AAP guidelines 1 explicitly recommend high-dose amoxicillin-clavulanate (90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate in 2 divided doses) as first-line treatment for children with:
- Recent amoxicillin use within 30 days
- Concurrent conjunctivitis (otitis-conjunctivitis syndrome)
- Desire for β-lactamase coverage
The "mucoid" descriptor suggests possible β-lactamase-producing organisms (H. influenzae or M. catarrhalis), making high-dose amoxicillin-clavulanate the appropriate first-line choice rather than amoxicillin alone 1.
Specific Dosing Calculation
For this 36 kg child:
- Amoxicillin component: 90 mg/kg/day × 36 kg = 3,240 mg/day
- Clavulanate component: 6.4 mg/kg/day × 36 kg = 230 mg/day
- Divided into 2 doses: 1,620 mg amoxicillin per dose (every 12 hours)
Formulation Selection
The FDA-approved Augmentin ES-600 formulation 2 provides the 14:1 ratio of amoxicillin to clavulanate (90/6.4 mg/kg/day) needed for high-dose therapy. This formulation demonstrated:
- 98.4% bacteriologic eradication of S. pneumoniae
- 92.6% eradication of H. influenzae
- 100% eradication of M. catarrhalis
- 89.1% clinical success at 2-4 days post-therapy 2
Treatment Duration
Prescribe for 10 days. While the 2013 guidelines 1 allow for shorter courses (5-7 days) in children ≥2 years with uncomplicated AOM, the presence of mucoid discharge suggests more severe or complicated infection warranting the full 10-day course. The FDA label studies 2 used 10-day regimens with excellent outcomes.
Twice-Daily Dosing Advantage
The twice-daily regimen offers several benefits over three-times-daily dosing:
- Improved compliance: 83.1% vs 72.8% adherence 3
- Lower diarrhea rates: 6.7% vs 10.3% 3
- Equivalent clinical efficacy to three-times-daily dosing 4, 5, 3
Common Pitfalls to Avoid
- Don't use standard-dose amoxicillin-clavulanate (45/6.4 mg/kg/day): This provides inadequate coverage for resistant S. pneumoniae and is not indicated for mucoid AOM
- Don't use the 7:1 ratio formulation: The older formulations with higher clavulanate (e.g., 40/10 mg/kg/day) cause more diarrhea without added benefit
- Don't underdose based on tablet strengths: Ensure the total daily amoxicillin dose reaches 90 mg/kg/day
Expected Adverse Effects
Counsel families that 2:
- Protocol-defined diarrhea occurs in 11-13% of patients
- Diaper rash/contact dermatitis in 6%
- Vomiting in 6.5-6.9%
- Most adverse effects are mild and transient
Treatment Failure Plan
If symptoms persist or worsen after 48-72 hours, the 2013 guidelines 1 recommend:
- Second-line: Ceftriaxone 50 mg/kg IM/IV daily for 3 days
- Consider tympanocentesis if available
- Evaluate for complications (mastoiditis, meningitis)
The high-dose amoxicillin-clavulanate regimen provides optimal coverage for both penicillin-resistant S. pneumoniae (up to MIC 4 mcg/mL) 2 and β-lactamase-producing organisms, making it the definitive first-line choice for this clinical scenario.